Vimian Group acquires veterinary allergy company in Denmark

Feb 08 2022

Vimian Group acquires veterinary allergy company in Denmark

Vimian Group has acquired Vet-Allergy, a veterinary allergy company in Denmark, to strengthen its position as a leading provider of veterinary allergy diagnostics and treatment in Scandinavia. Vet-Allergy has revenues of around EUR 1.3 million on an annual basis.

Vimian Group’s Specialty Pharma segment Nextmune has acquired Vet-Allergy. Founded in 2007 by Dr. Kristian Pedersen, Vet-Allergy offers allergy diagnostics and treatment for companion animals to veterinary clinics across Denmark. Today, the company is the leading provider of veterinary allergy solutions in Denmark with a full-service offering. The business enjoys deep customer relationships in Denmark serving over 300 veterinary clinics.

“Vet-Allergy is the only veterinary laboratory in Denmark that performs allergy testing and treatment of scale, and the acquisition offers an attractive opportunity for Nextmune to strengthen our position as a leading provider of allergy solutions for companion animals in Scandinavia. We can leverage Vet-Allergy’s strong relationships with veterinary clinics to accelerate sales of our allergy offering as well as our entire dermatology and specialty nutrition portfolio”, says Magnus Kjellberg, CEO of Vimian’s Specialty Pharma segment Nextmune.

”I am delighted to have found a sustainable home for my business in Nextmune. Their commitment to science and innovation represents an attractive fundamental for taking Vet-Allergy to the next level”, says Dr. Kristian Pedersen.

Vet Allergy was consolidated into Vimian’s Specialty Pharma segment on 31 January, 2022.